These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [TBL] [Abstract][Full Text] [Related]
5. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Bader TR; Beavers KL; Semelka RC Radiology; 2003 Mar; 226(3):675-85. PubMed ID: 12616016 [TBL] [Abstract][Full Text] [Related]
6. Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis. Petrovic BD; Nikolaidis P; Hammond NA; Martin JA; Petrovic PV; Desai PM; Miller FH Dig Dis Sci; 2007 Dec; 52(12):3499-506. PubMed ID: 17410447 [TBL] [Abstract][Full Text] [Related]
7. Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. Verloh N; Probst U; Utpatel K; Zeman F; Brennfleck F; Werner JM; Fellner C; Stroszczynski C; Evert M; Wiggermann P; Haimerl M PLoS One; 2019; 14(5):e0215752. PubMed ID: 31083680 [TBL] [Abstract][Full Text] [Related]
8. Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging. Martin DR; Lauenstein T; Kalb B; Lurie C; Kitajima H; Sharma P; Salman K; Moreira R; Farris AB; Spivey J; Martinez E; Hanish S; Adsay V J Magn Reson Imaging; 2012 Aug; 36(2):422-9. PubMed ID: 22566123 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of magnetic resonance parametric mapping for non-invasive assessment of liver fibrosis in patients with primary sclerosing cholangitis. Mesropyan N; Kupczyk P; Kukuk GM; Dold L; Weismueller T; Endler C; Isaak A; Faron A; Sprinkart AM; Pieper CC; Kuetting D; Strassburg CP; Attenberger UI; Luetkens JA BMC Med Imaging; 2021 Apr; 21(1):65. PubMed ID: 33827475 [TBL] [Abstract][Full Text] [Related]
11. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI. Jang YJ; Cho SH; Bae JH; Kim GC; Ryeom H; Kim HJ; Shin KM; Lee HJ Ann Hepatol; 2013; 12(6):926-34. PubMed ID: 24114823 [TBL] [Abstract][Full Text] [Related]
13. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019 [TBL] [Abstract][Full Text] [Related]
14. An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis. Schulze J; Lenzen H; Hinrichs JB; Ringe B; Manns MP; Wacker F; Ringe KI Clin Gastroenterol Hepatol; 2019 Jan; 17(1):192-199.e3. PubMed ID: 29775791 [TBL] [Abstract][Full Text] [Related]
15. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study. Verloh N; Utpatel K; Haimerl M; Zeman F; Beyer L; Fellner C; Brennfleck F; Dahlke MH; Stroszczynski C; Evert M; Wiggermann P Sci Rep; 2018 Apr; 8(1):6207. PubMed ID: 29670136 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease. Hayashi T; Saitoh S; Fukuzawa K; Tsuji Y; Takahashi J; Kawamura Y; Akuta N; Kobayashi M; Ikeda K; Fujii T; Miyati T; Kumada H Gut Liver; 2017 Sep; 11(5):674-683. PubMed ID: 28651300 [TBL] [Abstract][Full Text] [Related]
17. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. de Vries EM; Verheij J; Hubscher SG; Leeflang MM; Boonstra K; Beuers U; Ponsioen CY J Hepatol; 2015 Nov; 63(5):1212-9. PubMed ID: 26095184 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis. Ding Y; Rao S; Yang L; Chen C; Zeng M Radiol Med; 2016 Nov; 121(11):821-827. PubMed ID: 27449761 [TBL] [Abstract][Full Text] [Related]
19. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid. Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT Invest Radiol; 2012 Nov; 47(11):649-55. PubMed ID: 23011189 [TBL] [Abstract][Full Text] [Related]
20. Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials. Huh J; Ham SJ; Cho YC; Park B; Kim B; Woo CW; Choi Y; Woo DC; Kim KW BMC Med Imaging; 2019 Nov; 19(1):89. PubMed ID: 31729971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]